Genomize, a leader in high-end digital solutions for bioinformatics analysis of next-generation sequencing (NGS) data, and Genomenon, a leading genomic intelligence company, announced their partnership to integrate data from Mastermind Genomic Intelligence Platform and Cancer Knowledge Base (CKB) into the Genomize’s SEQ Platform. This collaboration will enable Genomize to incorporate both germline and somatic curated data from Genomenon, setting a new benchmark for comprehensive genomic interpretation.
The integration of Mastermind and CKB into Genomize’s workflow enhances the SEQ Platform’s ability to deliver rapid, precise, and actionable insights for researchers and clinicians. Mastermind offers an unparalleled genomic literature database, while CKB provides expertly curated somatic variant evidence. Together, they will empower Genomize users with a holistic view of genomic data, bridging the gap between research and clinical applications.
Also Read: Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer
“We are thrilled to partner with Genomenon to integrate both Mastermind and CKB into our platform,” said Erşen Kavak, CEO of Genomize. “This collaboration reinforces our commitment to providing the most comprehensive and accurate genomic insights, ultimately improving patient outcomes and advancing precision medicine.”
“By partnering with Genomize, we’re expanding access to our curated genomic data, reaching a wider audience, including organizations in the Europe, Middle East, and Asia through Genomize‘s operations,” said Mike Klein, CEO of Genomenon. “The integration will ensure that their users have access to the most complete and up-to-date genomic insights available, facilitating more informed decision-making in both research and clinical settings.”
SOURCE: PRWeb